These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7965636)

  • 41. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
    Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons.
    Stein MD; Piette J; Mor V; Wachtel TJ; Fleishman J; Mayer KH; Carpenter CC
    J Gen Intern Med; 1991; 6(1):35-40. PubMed ID: 1999744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Survival of patients following the diagnosis of AIDS in the Amsterdam region, 1982-1991].
    Bindels PJ; Krol A; Mulder-Folkerts DK; van den Hoek JA; Coutinho RA
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):513-8. PubMed ID: 8139710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.
    Lundgren JD; Barton SE; Katlama C; Ledergerber B; González-Lahoz J; Pinching AJ; Proenca R; Hemmer R; Pedersen C; Phillips AN
    Arch Intern Med; 1995 Apr; 155(8):822-8. PubMed ID: 7717790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in insurance status and access to care for persons with AIDS in the Boston Health Study.
    Weissman JS; Makadon HJ; Seage GR; Massagli MP; Gatsonis CA; Craven DE; Stone VE; Bennett IA; Epstein AM
    Am J Public Health; 1994 Dec; 84(12):1997-2000. PubMed ID: 7998646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
    Vella S; Giuliano M; Floridia M; Chiesi A; Tomino C; Seeber A; Barcherini S; Bucciardini R; Mariotti S
    AIDS; 1995 Jan; 9(1):51-6. PubMed ID: 7893441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
    Stambuk D; Hawkins D; Gazzard BG
    J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.
    Salmon-Ceron D; Fontbonne A; Saba J; May T; Raffi F; Chidiac C; Patey O; Aboulker JP; Schwartz D; Vildé JL
    J Infect Dis; 1995 Sep; 172(3):656-64. PubMed ID: 7658056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival experience of 789 children with the acquired immunodeficiency syndrome.
    Turner BJ; Denison M; Eppes SC; Houchens R; Fanning T; Markson LE
    Pediatr Infect Dis J; 1993 Apr; 12(4):310-20. PubMed ID: 8483626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of resource utilization for hospitalized patients with Pneumocystis carinii pneumonia (PCP): a summary of effects from the multi-city study of quality of PCP care.
    Horner RD; Bennett CL; Achenbach C; Rodriguez D; Adams J; Gilman SC; Cohn SE; Dickinson GM; DeHovitz JA; Weinstein RA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):379-85. PubMed ID: 8673547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Who is providing ambulatory care to Medicaid beneficiaries with acquired immunodeficiency syndrome in New York State?
    Howell EM; Keyes M; Mason ML; Turner BJ
    Arch Fam Med; 1992 Nov; 1(2):251-4. PubMed ID: 1341602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower socioeconomic status and shorter survival following HIV infection.
    Hogg RS; Strathdee SA; Craib KJ; O'Shaughnessy MV; Montaner JS; Schechter MT
    Lancet; 1994 Oct; 344(8930):1120-4. PubMed ID: 7934494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
    Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
    Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of treatment and prophylaxis on presentation and survival of patients with AIDS in Milan.
    Monforte A; Mainini F; Musicco M; Formenti T; Mena M; Bini T; Moroni M
    Lancet; 1995 Dec; 346(8988):1488. PubMed ID: 7491007
    [No Abstract]   [Full Text] [Related]  

  • 56. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study.
    Montaner JS; Lawson LM; Gervais A; Hyland RH; Chan CK; Falutz JM; Renzi PM; MacFadden D; Rachlis AR; Fong IW
    Ann Intern Med; 1991 Jun; 114(11):948-53. PubMed ID: 2024862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pneumocystis carinii pneumonia associated with acquired immunodeficiency syndrome in pregnancy: a report of three maternal deaths.
    Minkoff H; deRegt RH; Landesman S; Schwarz R
    Obstet Gynecol; 1986 Feb; 67(2):284-7. PubMed ID: 3484811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients.
    Girard PM; Landman R; Gaudebout C; Lepretre A; Lottin P; Michon C; De Truchis P; Matheron S; Camus F; Farinotti R
    Lancet; 1989 Jun; 1(8651):1348-53. PubMed ID: 2567372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of Medicaid expenditures after AIDS diagnosis.
    Markson LE; McKee L; Mauskopf J; Houchens R; Fanning TR; Turner BJ
    Health Care Financ Rev; 1994; 15(4):43-59. PubMed ID: 10172155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.